Brad Kline
Impact in
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Cells and Metastasis
-
- Cell Adhesion Molecules Research
Papers in
- Oncology 6
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 2
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Nicholas C. Nicolaides (5 shared papers)Luigi Grasso (4 shared papers)Philip M. Sass (3 shared papers)Yuhong Zhou (3 shared papers)Eric Routhier (3 shared papers)Wolfgang Ebel (2 shared papers)Katherine A. Rybinski (2 shared papers)Brian E. Tomkowicz (2 shared papers)
- Journals
- Oncotarget (2 papers)Journal of Nuclear Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)The FASEB Journal (1 paper)American Journal of Ophthalmology (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Brad Kline
14 papers receiving 327 citations
Peers
Comparison fields: 5 of 50
- Oncology 106
- Immunology and Allergy 24
- Ophthalmology 30
- Radiology, Nuclear Medicine and Imaging 74
- Immunology 56
Countries citing papers authored by Brad Kline
This map shows the geographic impact of Brad Kline's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Kline with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Kline more than expected).
Fields of papers citing papers by Brad Kline
This network shows the impact of papers produced by Brad Kline. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Kline. The network helps show where Brad Kline may publish in the future.
Co-authors
The 25 scholars most cited alongside Brad Kline, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 123 | |
| 2 | 2006 | 39 | |
| 3 | 2015 | 32 | |
| 4 | 2024 | 29 | |
| 5 | 2010 | 27 | |
| 6 | 2024 | 22 | |
| 7 | 2020 | 20 | |
| 8 | 2016 | 16 | |
| 9 | 2005 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 3 | |
| 13 | 2006 | 2 | |
| 14 | 2023 | 1 |
About Brad Kline
Brad Kline is a scholar working on Oncology, Cancer Research, Immunology and Allergy, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 348 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Cell Adhesion Molecules Research (2 papers), CAR-T cell therapy research (2 papers), Protease and Inhibitor Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Oncology (106 citations), Immunology and Allergy (24 citations), Ophthalmology (30 citations), Radiology, Nuclear Medicine and Imaging (74 citations) and Immunology (56 citations). Brad Kline has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Nicholas C. Nicolaides, Luigi Grasso, Philip M. Sass, Yuhong Zhou, Eric Routhier, Wolfgang Ebel, Katherine A. Rybinski, Brian E. Tomkowicz, Brian Thomas Foley and Qimin Chao. Their work appears in journals such as Oncotarget, Journal of Nuclear Medicine, Proceedings of the National Academy of Sciences, The FASEB Journal and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.